We investigated whether CXCR2 blockade resulted in any changes in infarct size, but no difference between SB225002 treatment and vehicle was observed (Figure 6D), indicating that CXCR2-mediated signals do not contribute substantially to brain injury in the current experimental model of cerebral ischemia. This evidence concerns the gene CXCR2 and brain ischemia.